as on October 30, 2025 at 1:29 am IST
Day's Low
Day's High
1.96%
Downside
1.14%
Upside
52 Week's Low
52 Week's High
36.74%
Downside
8.82%
Upside
Check Xenon Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.2B
EPS (TTM)
-4.2886
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-18.61
Industry PE ratio
8.355964912280701
PEG Ratio
-0.06
EBITDA
-315.5M
Revenue (TTM)
7.5M
Profit Margin
0.00%
Return On Equity TTM
-37.65%
Track how Xenon Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Xenon Pharmaceuticals Inc in the last 5 years
Lowest (-58.70x)
September 30, 2025
Today (-18.61x)
October 29, 2025
Industry (8.36x)
October 29, 2025
Highest (-10.66x)
September 30, 2021
Today’s Price to Earnings Ratio: -18.61x
Compare market cap, revenue, PE, and other key metrics of Xenon Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.2B | 342.1% | -18.61 | 0.00% | |
| BUY | $62.7B | 285.91% | -505.15 | -12.96% | |
| NA | $36.5B | NA | NA | -3.89% | |
| BUY | $108.0B | 104.04% | 29.95 | 31.86% | |
| BUY | $62.0B | 17.76% | 14.75 | 31.37% |
The Xenon Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Xenon Pharmaceuticals Inc investment value today
Current value as on today
₹1,06,234
Returns
₹6,234
(+6.23%)
Returns from Xenon Pharmaceuticals Inc Stock
₹1,173 (+1.17%)
Dollar Returns*
₹5,061 (+5.06%)
Based on 24 analysts
95.83%
Buy
4.17%
Hold
0.00%
Sell
Based on 24 analysts, 95.83% of analysts recommend a 'BUY' rating for Xenon Pharmaceuticals Inc. Average target price of $55.03
Get share price movements and forecasts by analysts on Xenon Pharmaceuticals Inc.
What analysts predicted
23.19%UPSIDE
Target Price
$55.03
Current Price
$42.27
Analyzed by
24 Analysts
Target
$55.03
Xenon Pharmaceuticals Inc target price $55.03, a slight upside of 23.19% compared to current price of $42.27. According to 24 analysts rating.
Search interest for Xenon Pharmaceuticals Inc Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:39% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 2.51M → 7.5M (in $), with an average increase of 66.5% per quarter
Price Rise
![]()
In the last 1 month, XENE stock has moved up by 8.9%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.2% return, outperforming this stock by 65.4%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.7% return, outperforming this stock by 118.8%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -65.04M → -84.70M (in $), with an average decrease of 30.2% per quarter
| Organisation | Xenon Pharmaceuticals Inc |
| Headquarters | 200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 |
| Industry | Health Technology |
| CEO | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Thomas Patrick Kelly J.D. | Chief Financial Officer |
Ms. Shelley McClCoskey B.A. | Executive Vice President of Human Resources |
Dr. Matthew D. Ronsheim Ph.D. | Chief Operating Officer |
Dr. Robin P. Sherrington Ph.D. | Executive Vice President of Strategy & Innovation |
Dr. James R. Empfield Ph.D. | Executive Vice President of Drug Discovery |
Mr. Darren S. Cline M.B.A. | Chief Commercial Officer and Member of Executive Team |
J.P. Gilbert | Senior Director |
Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. | President, CEO, Principal Accounting Officer & Director |
Ms. Andrea DiFabio J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Christopher John Kenney M.D. | Chief Medical Officer |
Xenon Pharmaceuticals Inc share price today is $42.27 as on at the close of the market. Xenon Pharmaceuticals Inc share today touched a day high of $42.75 and a low of $41.44.
Xenon Pharmaceuticals Inc share touched a 52 week high of $46 on and a 52 week low of $26.74 on . Xenon Pharmaceuticals Inc stock price today i.e. is closed at $42.27,which is 8.11% down from its 52 week high and 58.08% up from its 52 week low.
Xenon Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Xenon Pharmaceuticals Inc (XENE) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Xenon Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Xenon Pharmaceuticals Inc share’s latest price of $42.27 as on October 30, 2025 at 1:29 am IST, you will get 0.2366 shares of Xenon Pharmaceuticals Inc. Learn more about
fractional shares .
Xenon Pharmaceuticals Inc stock has given 342.1% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?